Skip to main content

Table 2 Mutational analysis, clinical data and prenatal diagnosis of combined MMA and HC families

From: Prenatal diagnosis using genetic sequencing and identification of a novel mutation in MMACHC

No.

Proband

Mutation Maternal

Mutation Paternal

Onset age

Clinical data

Follow-up

Fetus Genotype

HC (μM)

MMA (μM)

Ocular abnormalit-ies

(age and clinical details)

1*#

/

220delK

W203X

1 months

43

20.8

NA.

Dead of severe malnutrition at 6 months old

W203X, 220delK

2

R132X

W203X

R132X

6 months

99

187.3

Normal^

1.5y,developmental delay HC decreased to 60 μM

 

W203X

3

G155R

G155R

c.567dupT

1 month

NA

75.1

nystagmus

MMA decreased to 24.6 μM

 

c.567dupT

4#

/

W203X

220delK

3 weeks

NA.

Dead at 1 month old

 

5#

/

R73X

220delK

2 months

NA.

Dead at 8 month old

 

6*

R206W

R206W

W203X

40 days

158

45.1

nystagmus

3y,developmental delay,

R206W,

W203X

HC, MMAare normal

——

7

W203X

W203X

220delK

10 days

131

958.9

nystagmus

developmental delay, malnutrition

 

220delK

8*

W203X

W203X

W203X

2 weeks

174

215.2

Normal^

15 months, taking medicine promptly and properly for a period of time, the patient has being in good recovery

——,

W203X

——

9#

/

220delK

W203X

NA.

NA.

Dead at 4 months old

 

10

W203X

W203X

W203X

3 months

108

29.4

Visual inattention nystagmus

6 months, Can’t raise his head, developmental delay

 

W203X

  1. Note: *indicates prenatal diagnosis families; # indicates the proband in the family was dead; / indicates that the genotype of the dead proband was not available; ——indicates no mutation was detected; ^ indicates the proband’s parents said it’s normal without test
  2. HC:value of serum homocysteine (reference value:5-15 μM)
  3. MMA:value of urine methylmalonic acid (reference value:0.2-3.6 μM)
  4. NA.:not avaliable,bacause the patient is from other hospital or can’t get through telephone